One of the hypotheses presented was that increase myonectin/ERFE in subjects with diabetes and impaired glucose tolerance might be an effect of a response to metabolic stress from resistance to myonectin action or dysregulation of myonectin signaling and synthesis in response to hyperinsulinemia and hyperglycemia related to insulin resistance. The gene discussed is ERFE; the disease is hyperinsulinism.